Fig. 2
From: B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
Anti-CD20 therapy does not affect anti-tumor immune responses in murine colon cancer (MC38). a. Survival of MC38 tumor-bearing mice treated with saline (ctrl), anti-CD20, anti-PD-1, or anti-CD20 + anti-PD-1 (comb), n = 10. Ctrl vs CD20 log-rank p = 0.78; PD-1 vs comb p = 0.67; ctrl vs comb p < 0.0001. b Waterfall plot of groups in a, shown as percent change in tumor size relative to size at day 10